Stephen Davis
Affiliations
- Ceo at Acadia Pharmaceuticals Inc (ACAD), 2024-08-20
- Director at Bellicum Pharmaceuticals Inc (BLCM), 2023-01-05
- Director at Heron Therapeutics Inc. (HRTX), 2022-12-20
- Director at Synageva Biopharma Corp (GEVA), 2015-06-23
- Director at Furiex Pharmaceuticals Inc. (FURX), 2014-07-07
- Evp & Coo at Ardea Biosciences Inc. (RDEA), 2012-06-20
Insider Trading: Sales See All
Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
ACAD | $15.28 | 31,747 | $485,094.16 | 186,555 | 2024-08-19 | Filing |
ACAD | $16.94 | 11,427 | $193,573.38 | 155,231 | 2024-05-02 | Filing |
ACAD | $17.87 | 17,716 | $316,584.92 | 144,267 | 2024-04-08 | Filing |
ACAD | $17.87 | 8,858 | $158,292.46 | 161,983 | 2024-04-08 | Filing |
ACAD | $17.90 | 17,714 | $317,080.60 | 118,842 | 2024-03-27 | Filing |